Recent Posts
- Azurity Pharmaceuticals Announces Richard Blackburn as New CEO
- AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF FLEQSUVY™
- Azurity Pharmaceuticals Completes Acquisition of Arbor Pharmaceuticals
- Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of One Lot of Firvanq® (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Due to a Mix-Up of the Diluent Included in the Kit
- Arbor Supports Updated Clinical Recommendations for Restless Legs Syndrome
Recent Comments